SISTEMA INTEGRAL DE INFORMACIÓN ACADÉMICA - PÚBLICO

Trejo-Becerril C.
(Autor externo)

Obras con ISBN:0
Documentos en revistas:22
Colaboraciones en Tesis:0
Patentes:0
Obras con ISBN:No hay obras de este autor.
Documentos en revistas:
1.- Increased amounts of cell-free DNA released from a culture with a high content of cancer stem cells (2025)
 
2.- The non-vesicle cell-free DNA (cfDNA) induces cell transformation associated with horizontal DNA transfer (2024)
 
3.- TP53 oncogenic variants as prognostic factors in individuals with glioblastoma: a systematic review and meta-analysis (2024)
 
4.-

Hereditary diffuse gastric cancer (HDGC). An overview

(2022)
 
5.- In Vivo Rat Model to Study Horizontal Tumor Progression (2014)
 
6.- A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors (2007)
 
7.- Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines (2006)
 
8.- A proof-of-principle study of epigenetics therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer (2006)
 
9.- Response to gefitinib in bronchioloalveolar carcinoma in the absence of EGFR mutation (2005)
 
10.- A phase I study of hydralazine to demythylate and reactivate the expression of tumor suppressor genes (2005)
 
11.- Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study (2005)
 
12.- Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance (2005)
 
13.- Circulating nucleosomes and response to chemotherapy: An in vitro, in vivo and clinical study on cervical cancer patients (2003)
 
14.- Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy (2003)
 
15.- Induction chemotherapy with gemcitabine and oxaliplatin for locally advanced cervical carcinoma (2003)
 
16.- Neuroendocrine marker expression in cervical carcinomas of non-small cell type (2002)
 
17.- Correlation of tumor growth index with early treatment response in cervical carcinoma (2002)
 
18.- Membrane proteins in neoplasic and normal uterine cervix (2001)
 
19.- Immunohistochemical expression of p53 in breast carcinoma is associated with the intron 1 BglII polymorphism of the p53 gene (2000)
 
20.- Identification of peptides presented by HLA class I molecules on cervical cancer cells with HPV-18 infection (1999)
 
21.- Establishment and characterization of a cell line (CaLo) and a clone (KaLo), obtained from a cervix carcinoma and the effect of IL-2, IL-3, GM-CSF, M-CSF, TNF-a and IFN-? on its proliferation [ESTABLECIMIENTO Y CARACTERIZACION DE LA LINEA (1993)
 
22.- Proliferation of peripheral blood leukocytes in the presence of serum from patients with uterine cervix cancer and recombinant interleukin-2 [PROLIFERACION DE LEUCOCITOS DE SANGRE PERIFERICA EN PRESENCIA DE SUEROS DE PACIENTES CON CANCER CER (1992)
 
Colaboraciones en Tesis:No hay tesis de este autor.
Patentes:No hay patentes de este autor.